164605 | Aminopeptidase N (CD13), Human Serum

164605
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitéeDisponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Voir les Prix & la Disponibilité
      Click To Print This Page

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Prix & Disponibilité

      RéférenceDisponibilité Conditionnement Qté Prix Quantité
      164605-10UG
      Récupération des données relatives à la disponibilité...
      Disponibilité limitéeDisponibilité limitée
      En stock 
      Interrompu(e)
      Disponible en quantités limitées
      Disponibilité à confirmer
        Pour le restant : Nous vous tiendrons informé
          Pour le restant : Nous vous tiendrons informé
          Nous vous tiendrons informé
          Contacter le Service Clients

          Ampoule plast. 10 μg
          Prix en cours de récupération
          Le prix n'a pas pu être récupéré
          La quantité minimale doit être un multiple de
          À la validation de la commande Plus d'informations
          Vous avez sauvegardé ()
           
          Demander le prix
          Description
          OverviewNative aminopeptidase N purified from human serum. Aminopeptidase N is a single-chain, integral membrane protease with broad specificity that functions to remove N-terminal amino acids from peptides. It also acts as a receptor for coronavirus and is known to play a role in angiogenesis, HIV entry, and in degradation of extracellular matrix as a result of tumor invasion.
          Catalogue Number164605
          Brand Family Calbiochem®
          SynonymsAPN/CD13, Aminopeptidase N
          References
          ReferencesBhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.
          Product Information
          Unit of DefinitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol L-leucine-p-nitroanilide) per min at 37°C, pH 7.2.
          EC number3.4.11.2
          FormLiquid
          FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 1 mM CaCl₂, pH 8.0.
          Applications
          Biological Information
          Purity≥92% by SDS-PAGE
          SourcePrepared from human serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          Specific Activity≥450 mU/mg protein
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificats d'analyse

          TitreNuméro de lot
          164605

          Références bibliographiques

          Aperçu de la référence bibliographique
          Bhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.
          Fiche technique

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision06-September-2007 RFH
          SynonymsAPN/CD13, Aminopeptidase N
          DescriptionNative aminopeptidase N purified from human serum. Aminopeptidase N is a single-chain, integral membrane protease with broad specificity that functions to remove N-terminal amino acids from peptides. It also acts as a receptor for coronavirus and is known to play a role in angiogenesis, HIV entry, and in degradation of extracellular matrix as a result of tumor invasion. Activity is inhibited by amastatin, actinonin, and bestatin (Cat. No. 200484) (~150 µM).
          FormLiquid
          FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 1 mM CaCl₂, pH 8.0.
          SourcePrepared from human serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          EC number3.4.11.2
          Purity≥92% by SDS-PAGE
          Specific activity≥450 mU/mg protein
          Unit definitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol L-leucine-p-nitroanilide) per min at 37°C, pH 7.2.
          Storage ≤ -70°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Toxicity Standard Handling
          ReferencesBhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.